Treatment of uveitis and ankylosing spondylitis refractory to three tumor necrosis factor alpha inhibitors drugs with golimumab

Reumatol Clin (Engl Ed). 2020 Jan-Feb;16(1):64-65. doi: 10.1016/j.reuma.2018.01.003. Epub 2018 Feb 19.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / therapeutic use
  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • Humans
  • Infliximab / therapeutic use
  • Methotrexate / therapeutic use
  • Spondylitis, Ankylosing / complications
  • Spondylitis, Ankylosing / drug therapy*
  • Sulfasalazine / therapeutic use
  • Treatment Failure
  • Tumor Necrosis Factor Inhibitors / therapeutic use*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Uveitis / drug therapy*
  • Uveitis / etiology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Tumor Necrosis Factor Inhibitors
  • Tumor Necrosis Factor-alpha
  • Sulfasalazine
  • golimumab
  • Infliximab
  • Adalimumab
  • Methotrexate